Today’s CSR movers
ETR 4.1 ▲ 1.2
CSX 4.0 ▲ 1.2
C 4.0 ▲ 1.2
PCG 4.1 ▲ 1.2
CMCSA 3.1 ▲ 0.8
NWSA 5.0 ▲ 0.3
VRSN 3.6 ▼ 0.4
ES 2.2 ▼ 0.8
SRE 2.9 ▼ 1.2
AEE 2.8 ▼ 1.2
Health Care · NYSE NYSE · CRL

Charles River Laboratories

$224.35 -$4.71 -2.10% CLOSE 07.17.26
Convergence score
4.1 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Aggregated across multiple horizons
Consensus target (12mo)
$227.54 +1.4%
Range $135.00 — $265.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.17.26
UV Convergence Score
REPORT 07.17.26
4.1
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.5
Analyst average
4.3
Multi-signal aggregate How CSR works →
Day Range
52W Range
Volume
Avg Vol
Mkt Cap
P/E
EPS (TTM)
Div Yield
Beta
1.40
Today's convergence

Convergence score sits at 4.1 . Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
CSR direction
STRONG BULLISH
Last close
$224.35
Sector
Health Care
Valuation
Three horizons
UPDATED 07.17.26
Short term
0–3 MO
No target Strong Buy
Medium term
3–12 MO
$221-1.6% Buy
Long term
12–36 MO
No target
Open valuation
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$227.54 +1.4%
RANGE $135.00 — $265.00
Analyst consensus
Consensus rating Buy
Blended score 4.2 / 5
Analysts tracked 63
Open analysts
Financials
Key metrics
LATEST
P/E
EPS (TTM)
Mkt Cap
Div Yield
Beta
1.40
52W Range
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.17.26
Short term
0–3 MO
Strong Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$221 -1.6%
RANGE $160 – $265
$160NOW $224.35$265

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Consensus target
No target available
Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Multi-source consensus & targets.

4 PANELS · UPDATED 07.17.26
Analyst consensus
Rating Blended score Panels Analysts
Buy 4.2 4 63
Price targets
Coverage Low Mean Median High Upside
All panels $135.00 $227.54 $265.00 +1.4%
Rating distribution
Coverage SB B H S SS
All panels 12 3 1
Rating trend
Period Rating Avg Analysts
Current Strong Buy 4.47 15
1 Mo Ago Strong Buy 4.44 16
2 Mo Ago Strong Buy 4.44 16
3 Mo Ago Strong Buy 4.44 16
Most recent analyst action
Date
7/13/2026
Firm
Mizuho
Action
Boost Target
Rating
Neutral
Target
$230.00
Financials

Full financial snapshot.

UPDATED 07.17.26
Quote snapshot
Prev Close
Open
Day Low
Day High
Bid
Ask
52W Low
52W High
50D Avg
191.98
200D Avg
184.35
Volume
Avg Vol
10D Avg Vol
52W Change
+44.80%
S&P 52W Change
Valuation ratios
P/E (TTM)
P/E (Fwd)
18.20
PEG (Fwd)
0.12
P/S
2.68
P/B
3.67
Book Value
61.05
EV/Revenue
3.40
EV/EBITDA
15.38
Mkt Cap
10.81B
Enterprise Val
13.68B
Profitability & returns
Profit Margin
-4.59%
Gross Margin
34.46%
Operating Margin
12.97%
EBITDA Margin
22.09%
Return on Assets
4.26%
Return on Equity
-5.87%
Growth
Revenue Growth (YoY)
Earnings Growth (YoY)
Earnings Growth (Q)
Balance sheet & cash flow
Total Revenue
4.03B
EBITDA
889.62M
Total Cash
Total Debt
3.06B
Cash / Share
Revenue / Share
Free Cash Flow
510.02M
Operating CF
607.03M
Debt / Equity
1.03
Current Ratio
1.36
Quick Ratio
0.82
Dividend
Fwd Dividend
Dividend Yield
Payout Ratio
5Y Avg Yield
Ex-Div Date
Share statistics
Shares Out
48.17M
Float
47.65M
Shares Short
4.35M
% Short of Float
9.14%
Short Ratio
5.13
% Held Insiders
0.97%
% Held Institutions
121.75%
Calendar & events
Next Earnings
Aug 5, 2026
Fiscal Year End
Most Recent Qtr
Last Split
Split Date
Company
Industry
Employees